Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 CoagulopathyCOVID-19 응고병증의 병인에서 새로운 동맹자로서의 항인지질 증후군의 항원 및 항체Review Published on 2022-04-292022-09-12 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 진단, [키워드] age-matched control Ally antibody Anticoagulant Antigen antiphospholipid antibodies Antiphospholipid syndrome assays association B2GP1 deficiency carried caused changed Coagulopathy conducted COVID-19 COVID-19 coagulopathy COVID-19 complications COVID-19 patients criteria deficiency Elderly patient greater heterogeneous mechanism New occur Patient performed physiological functions Population predisposition Prevalence prothrombotic reduced reported SARS-CoV2 infection syndrome the disease thrombotic event was measured [DOI] 10.3390/ijms23094946 PMC 바로가기 [Article Type] Review
Clinical Features and Management of COVID-19–Associated HypercoagulabilityReview article Published on 2022-03-012022-10-05 Journal: Cardiac electrophysiology clinics [Category] SARS, 바이오마커, 임상, [키워드] antithrombotic therapy Arterial thrombosis clinical COVID-19 coagulopathy hypercoagulability Venous Thromboembolism [DOI] 10.1016/j.ccep.2021.10.005 [Article Type] Review article
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography studyResearch Published on 2021-11-062022-10-29 Journal: Thrombosis Journal [Category] COVID-19, [키워드] activated acute respiratory distress syndrome (ARDS) Admission amplitude analysed Analysis bleeding Coagulation Coagulopathy Corona virus disease 2019 (COVID-19) COVID-19 COVID-19 coagulopathy COVID-19 patient critically-ill D-dimer difference Disseminated intravascular coagulopathy elevated evaluated Evolution fibrinogen Fibrinogen levels functional hypercoagulability hypercoagulable ICU ICU admission intensive care Laboratory limit mechanical ventilation mechanically ventilated non-survivor Non-survivors observation period parameter Patient patients patients with COVID-19 performed Platelet Prothrombin time reported Result Severe COVID-19 pneumonia significant difference significantly supplementary material survivor Thromboelastography (TEG) thrombosis variable was performed [DOI] 10.1186/s12959-021-00331-5 PMC 바로가기 [Article Type] Research
Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic centerArticle Published on 2021-05-012023-07-11 Journal: Journal of vascular surgery. Venous and lymphatic [Category] SARS, [키워드] COVID-19 coagulopathy COVID-19 VTE Hypercoagulable state in COVID-19. [DOI] 10.1016/j.jvsv.2020.09.006 PMC 바로가기
Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumoniaComment Published on 2020-12-012023-07-13 Journal: Thrombosis research [Category] SARS, [키워드] anticoagulation COVID-19 COVID-19 coagulopathy D-dimer SARS-CoV-2 [DOI] 10.1016/j.thromres.2020.09.030 PMC 바로가기 [Article Type] Comment